KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Debt Ratio: 2019-2025

Historic Debt Ratio for Rigel Pharmaceuticals (RIGL) over the last 6 years, with Sep 2025 value amounting to 0.25.

  • Rigel Pharmaceuticals' Debt Ratio fell 42.55% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 42.55%. This contributed to the annual value of 0.36 for FY2024, which is 28.42% down from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Debt Ratio stood at 0.25, which was down 14.88% from 0.29 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Debt Ratio ranged from a high of 0.52 in Q3 2023 and a low of 0.09 during Q1 2021.
  • For the 3-year period, Rigel Pharmaceuticals' Debt Ratio averaged around 0.42, with its median value being 0.46 (2024).
  • Its Debt Ratio has fluctuated over the past 5 years, first spiked by 220.19% in 2022, then crashed by 42.55% in 2025.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Debt Ratio stood at 0.12 in 2021, then soared by 146.85% to 0.29 in 2022, then soared by 73.07% to 0.51 in 2023, then fell by 28.42% to 0.36 in 2024, then tumbled by 42.55% to 0.25 in 2025.
  • Its Debt Ratio was 0.25 in Q3 2025, compared to 0.29 in Q2 2025 and 0.34 in Q1 2025.